Biểu đồ giá cổ phiếu CNTB
CNTB Dự đoán giá cổ phiếu
Connect Biopharma Holdings Ltd
$2.4
-2.04%
$-0.05
Khi đóng cửa: Apr 28, 16:00:00 GMT-4
$2.4
0%
$0
Phiên trước giờ: Apr 29, 05:53:41 GMT-4
Quay lại
Connect Biopharma Holdings Ltd (CNTB) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$2.45
Giá mở cửa
$2.46
Phạm vi ngày
$2.35 - $2.5
Phạm vi 52 tuần
$0.65 - $3.82
Khối lượng
148.2K
Khối lượng trung bình
198.0K
Tỷ suất cổ tức
--
EPS (TTM)
-0.81
Vốn hóa thị trường
$133.7M
CNTB là gì?
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 62 full-time employees. The company went IPO on 2021-03-19. The firm is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The firm has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.
